When will current Series A startups raise their Series B? Someone recently asked me this question, so I built a prediction model to help generate an answer. Keep reading as I discuss my process and give actual Series B predictions. Where to begin? I began by pulling together metrics that made sense for a company trying to raise a Series B. My thinking first went to a company's finances…
Arc portfolio company ChargePoint announced that it will become a public company through a business combination with Switchback Energy Acquisition Corporation (NYSE:SBE), valued at $2.4 Billion. The official press release can be found here. ChargePoint, Inc. to Become Public Company, Advancing EV Charging Network’s Reach Across North America and Europe Business Combination with Switchback Energy…
PolyPid successfully completed its initial public offering on the NASDAQ, June 30th 2020. Arc Ventures first invested in the company in 2016. You can find more information about the investment here. PolyPid's original press release can be found on its website. PolyPid Ltd. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option…
Ayala is an Arc Ventures portfolio company since 2018 . The official press release can be found on the company's website. REHOVOT, Israel & WILMINGTON, Del., May 12, 2020 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and…
Orgenesis, a pioneering, global biotech company committed to lowering costs, accelerating commercialization, and transforming the delivery of cell and gene therapies (CGTs), announces it has entered into an agreement to acquire the assets of Tamir Bio, including ranpirnase, TamirBio’s broad spectrum anti-viral platform.
Intuitive acquires Orpheus Medical to expand informatics platform for hospitals. “Combining both companies’ innovative technologies with Intuitive’s global reach and resources will enable current and future customers easier and faster access to their data,” said Gaddi Menahem, CEO of Orpheus Medical.
Vayyar Imaging today announced it closed a $109 million Series D financing round led by Koch Disruptive Technologies (Koch), with Regal Four and all existing investors including Battery Ventures, Bessemer Ventures, ICV, ITI, WRVI Capital, Claltech, bringing the total capital raised to-date to $188 million USD.
